Gilead Sciences CEO says drug remdesivir will be available this week

Gilead Sciences CEO says drug remdesivir will be available this week

As per the announcement from Dan O’Day, CEO Gilead Sciences, anti-viral drug remdesivir, which was approved on Friday for emergency use by the FDA, is expected to be available to treat Covid-19 patients as early as this week. O’Day said his company has donated its entire stock of remdesivir — totaling roughly 1.5mn vials — to the govt, who will dispense the drug across the states on demand basis.

Milan
Milan
Top in U.S.
Get the App